Civic AI
Civic AI
Procurement intelligence
grants_govHRSA-26-092
Open

Hereditary Hemorrhagic Telangiectasia (HHT) Center

Department of Health and Human Services
Response deadline
Jul 10, 2026
Closed
Date posted
Jun 8, 2026

Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.

Classifications

Documents (2)

  • HRSA-26-092 Final.pdf
    application/pdf477 KB
    Download
  • HRSA 26-092 HHT Center Program FAQ.pdf
    application/pdf83 KB
    Download

Contacts

Explore more

Browse all opportunitiesFederal contract opportunitiesState & local contractsFind government contractsBrowse agenciesMore from Department of Health and Human Services